STOCK TITAN

BioLife Solutions officer plans $48.6K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

BioLife Solutions, Inc. (BLFS) officer Karen Foster reported a planned sale of 2,577 common shares, with an aggregate market value of $48,576.45 and an approximate sale date of March 23, 2026. She acquired 2,577 shares from the issuer through exercise of stock options on March 23, 2026, paying cash. The reported date for plan adoption or instruction, if relying on Rule 10b5-1, is December 4, 2025. Prior sales are identified as Rule 10b5-1 transactions.

Shares to be sold 2,577 shares Planned sale; approximate sale date March 23, 2026.
Aggregate market value $48,576.45 Shares to be sold.
Shares outstanding 48,300,000 shares Reported for BioLife Solutions, Inc.
Shares acquired through option exercise 2,577 shares Acquired from the issuer on March 23, 2026; payment was cash.
Prior sale 500 shares; $10,002.00 gross proceeds March 9, 2026; identified as a Rule 10b5-1 sale.
Prior sale 96,923 shares; $1,953,163.22 gross proceeds March 5, 2026; identified as a Rule 10b5-1 sale.
Prior sale 418 shares; $8,669.32 gross proceeds March 3, 2026; identified as a Rule 10b5-1 sale.
Prior sale 335 shares; $8,572.65 gross proceeds January 6, 2026; identified as a Rule 10b5-1 sale.
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Exercise of Stock Options financial
"Nature of Acquisition Transaction: Exercise of Stock Options"
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BLFS shares did Karen Foster plan to sell?

Karen Foster, an officer of BioLife Solutions, Inc. (BLFS), reported a planned sale of 2,577 common shares with an aggregate market value of $48,576.45, scheduled approximately March 23, 2026.

What prior Rule 10b5-1 sales did Karen Foster report for BLFS?

Karen Foster's reported Rule 10b5-1 sales were 500 shares for $10,002.00 on March 9, 2026; 96,923 shares for $1,953,163.22 on March 5, 2026; 418 shares for $8,669.32 on March 3, 2026; and 335 shares for $8,572.65 on January 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading